SNDX – syndax pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals (SNDX) had its price target raised by Citigroup Inc. from $51.00 to $57.00. They now have a "buy" rating on the stock.
Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs [Yahoo! Finance]
Is Syndax (SNDX) Using ESOP Shares and New Drugs to Quietly Redefine Its Investment Story? [Yahoo! Finance]
Syndax Pharmaceuticals Inc (SNDX) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... [Yahoo! Finance]
Form S-8 Syndax Pharmaceuticals
Form 10-K Syndax Pharmaceuticals For: Dec 31
Form 8-K Syndax Pharmaceuticals For: Feb 26
Form 4 Syndax Pharmaceuticals For: Feb 09 Filed by: Metzger Michael A
Form 4 Syndax Pharmaceuticals For: Feb 09 Filed by: Goldan Keith A.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.